April 24, 2012
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|
Re: |
|
OncoSec Medical Incorporated |
|
|
|
Request for Withdrawal of Post Effective Amendment No. 1 to Registration Statement on Form S-1 (Registration No. 333-179146) |
Ladies and Gentlemen:
Pursuant to Rule 477 of the Securities Act of 1933, as amended, OncoSec Medical Incorporated (the “Company”) hereby requests the withdrawal of Post-Effective Amendment No. 1 to Registration Statement on Form S-1 (the “Post-Effective Amendment”) filed with the Securities Exchange Commission (the “Commission”) on April 17, 2012. The Post-Effective Amendment relates to the Company’s Registration Statement on Form S-1 (the “Registration Statement”) declared effective by the Commission on March 23, 2012. In lieu of the Post-Effective Amendment, the Company intends to file a post-effective amendment to the Registration Statement from Form S-1 to Form S-3 that will include the information set forth in the Post-Effective Amendment. No securities have been sold under the Post-Effective Amendment.
If you have any questions regarding this application for withdrawal, please contact Steven G. Rowles, Esq. of Morrison & Foerster LLP, counsel for the Company, at (858) 720-5100.
Very truly yours,
OncoSec Medical Incorporated
|
By: |
/s/ Punit Dhillon |
|
Punit Dhillon
President and Chief Executive Officer
OncoSec Medical Incorporated
cc: Steven G. Rowles, Esq., Morrison & Foerster LLP
OncoSec Medical Incorporated · 4690 Executive Drive Suite 250 · San Diego, California 92121
Telephone: (855) OncoSec (662-6732) or (858) 224-0090 · Fax: (858) 430-3832